Similar Items: Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring
- A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians)
- Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
- Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up
- High Patient Willingness to Grant Broad Consent for Real-World Data Use in Rheumatology—Implications for Real-World Data Platform Governance: Cross-Sectional Study